about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusToxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.Chronic superantigen exposure induces systemic inflammation, elevated bloodstream endotoxin, and abnormal glucose tolerance in rabbits: possible role in diabetes.Genotypic and phenotypic analysis of clinical isolates of Staphylococcus aureus revealed production patterns and hemolytic potentials unlinked to gene profiles and source.Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo.Temporal and Racial Differences Associated with Atopic Dermatitis Staphylococcusaureus and Encoded Virulence FactorsOmics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates.Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.Methicillin-resistant Staphylococcus aureus pneumonia in adults.Animal Models Used to Study Superantigen-Mediated Diseases.Adaptive Immunity Against Staphylococcus aureus.Elucidating the anti-Staphylococcus aureus antibody response by immunoproteomics.Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain events.A global Staphylococcus aureus proteome resource applied to the in vivo characterization of host-pathogen interactions.Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.Microarray-based identification of human antibodies against Staphylococcus aureus antigens.Enterotoxin Gene Cluster-Encoded SEI and SElN from Staphylococcus aureus Isolates are Crucial for the Induction of Human Blood Cell Proliferation and Pathogenicity in RabbitsSystemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndromeSuperantigens of a superbug: Major culprits of Staphylococcus aureus disease?The Superantigen Toxic Shock Syndrome Toxin-1 Alters Human Aortic Endothelial Cell Function.Draft Genome Sequence of USA100 Methicillin-Resistant Staphylococcus aureus Strain 209.Are we close to a vaccination against Staphylococcus aureus?Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.A Critical Role for HlgA in Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System
P2860
Q26780246-89F73611-3F4F-44C3-9C27-FEEB7011D14AQ33813616-79C085F3-566B-42DB-B50A-193BE679FC4CQ34916584-AE62B91B-289F-4FB6-A3B5-9C29826B48E6Q35031839-AF5552C5-14FF-4E0C-95A4-730B953908ADQ35153205-380F0211-FF0A-4505-840E-1F0C6EFF20D2Q35172347-97B9751F-0A22-4ED2-9FF4-0A068B1342E6Q35910386-DD18AE8B-FC24-4975-AFF7-F2292037A02EQ36001974-91994162-E572-4498-93C5-1D6DBEFC434FQ37016163-C59AD845-7A3C-408E-B382-862259B615DDQ37482861-29A45060-CC12-4B98-A685-7C8FA001634AQ37566435-9292875A-A8A7-4FD7-9FD0-FE91530C2C3CQ37737520-1FF9D5DD-4153-4C6D-A49D-27A9C3BFE8FDQ38210888-4508EE14-C02A-417C-8029-D6371215E83AQ38230203-9CFF57E7-E747-45D5-B2D3-51DA16E08939Q38671469-B44DC028-944C-4F37-9158-15ADBE804591Q38751767-E5F177FD-4F80-4333-83E4-15C5755FA4D0Q38924957-80602725-8F19-4F24-BA5F-8435E09AAB19Q39100547-8F4718E0-67C1-4331-AB87-8452594C696CQ40059636-E4056CB1-8DB6-4B10-8C89-8987130DB063Q40420550-B57E9862-B8C7-4454-ACD9-5104C03B28D8Q40718746-2B6693CC-C198-46F5-802C-9F7079616DC9Q41486894-9A2C6534-FEFF-4D59-8D88-CC103255234FQ42182419-A20F93D0-0E8B-4644-B2E2-D6DED01F9425Q42203147-98FB513B-077F-462B-8B60-9988C99A6B23Q42715966-1749F8D6-C13C-4B82-9271-B6B83FC10DECQ47327508-327F4D6F-44B8-4F0D-854E-076C3FD4B8E1Q48307205-2C5B1D79-F478-49CB-9668-264FCD6E32FBQ48827180-B0F855B7-F44B-4986-B2E6-D3BCA5F0F216Q55278118-6621EDC5-9DCE-4D8E-848E-99AB1A1EA5C8Q58723231-CCAB2858-E46C-4273-9F1D-196BA1531A19
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Vaccination against Staphylococcus aureus pneumonia
@ast
Vaccination against Staphylococcus aureus pneumonia
@en
type
label
Vaccination against Staphylococcus aureus pneumonia
@ast
Vaccination against Staphylococcus aureus pneumonia
@en
prefLabel
Vaccination against Staphylococcus aureus pneumonia
@ast
Vaccination against Staphylococcus aureus pneumonia
@en
P2093
P2860
P50
P356
P1476
Vaccination against Staphylococcus aureus pneumonia
@en
P2093
Adam R Spaulding
Christopher S Stach
Joseph A Merriman
Marnie L Peterson
P2860
P304
P356
10.1093/INFDIS/JIT823
P407
P577
2013-12-19T00:00:00Z